Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis

Postmenopausal osteoporosis increases susceptibility to low-trauma fractures due to reduced bone volume and microarchitectural deterioration. Daily nitrogen-containing bisphosphonates have shown antifracture efficacy in many studies and are the most commonly prescribed treatment for women with postm...

Descripción completa

Detalles Bibliográficos
Autores principales: Moro-Álvarez, María J, Díaz-Curiel, Manuel
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2546467/
https://www.ncbi.nlm.nih.gov/pubmed/18686745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2546467/
https://www.ncbi.nlm.nih.gov/pubmed/18686745

Ejemplares similares